158
Views
14
CrossRef citations to date
0
Altmetric
Research Article

High Mobility Group Box 1 in Cerebrospinal Fluid From Several Neurological Diseases at Early Time Points

, , , , , , , , & show all
Pages 480-484 | Received 16 Feb 2011, Published online: 10 Jun 2011

REFERENCES

  • Anderson, A., Covacu, R., Sunnemark, D., Darilov, A. I., Dal Bianco, A., Khademi, M., (2008). Pivotal advance: HMBG1 expression in active lesions human and experimental multiple sclerosis. Journal of Leukocyte Biology, 84, 1248–1255.
  • Eguchi, T., Nomura, Y., Hashiguchi, T., Masuda, K., Arata, M., Hazeki, D., (2009). An elevated value of high mobility group box 1 is a potent marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki disease. Still Neurocrit Care, 11(3), 362–368.
  • Ichiyama, T., Morishima, T., Isumi, H., Matsufuji, H., Matsubara, T., & Furukawa, S. (2004). Analysis of cytokine levels and NF-κB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine, 27, 31–37.
  • Johnston, M. V. (2004). Acute Encephalopathies, Nelson Textbook of Pediatrics, 17th ed. Tokyo: Saunders, 2023–2029.
  • Kim, J.-B., Choi, J. S., Yu, Y.-M., Nam, K., Piao, C.-S., Kim, S.-W., (2006). HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. Journal of Neuroscience, 26, 6413–6421.
  • Lima, J. E., Takayanagui, O. M., Garcia, L. V., & Leite, J. P. (2004). Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Brazilian Journal of Medical and Biological Research, 37, 19–26.
  • Lotze, M. T., & Tracey, K. J. (2005). High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nature Review of Immunology, 5, 331–342.
  • Mizuguchi, M., Yamanouchi, H., Ichiyama, T., & Shiomi, M. (2007). Acute encephalopathy associated with influenza and other viral infections. Acta Neurologica Scandinavica, 115(suppl. 186), 45–56.
  • Nakahara, T., Tsuruta, R., Kaneko, T., Yamashita, S., Fujita, M., Kasaoka, S., (2009). High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Semin Pediatr Infect Dis, 13(2), 79–84. PMID:12122956[PubMed - indexed for MEDLINE].
  • Ohta, T., Kikuchi, H., Hashi, K., & Kudo, Y. (1986). Nizofenone administration in the acute stage following subarachnoid hemorrhage. Journal of Neurosurgery, 64, 420–226.
  • Park, J. T. (2006). Acute Encephalopathies. Oski's Pediatrics Principles & Practice, 4th ed. Tokyo: Lippincott Williams & Wilkins, 2258–2263.
  • Sugaya, N. (2002). Influenza-associated encephalopathy in Japan. Semin Pediatr Infect Dis, 13, 79–84. Review.
  • Tang, D., Kang, R., Cao, L., Zhang, G., Yu, Y., Xiao, W., (2008). A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Critical Care Medicine, 36, 291–295.
  • Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., (1999). HMG-1 as a late mediator if endotoxin lethality in mice. Science, 285, 248–251.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.